Login / Signup
David E Axelrod
ORCID
Publication Activity (10 Years)
Years Active: 2017-2023
Publications (10 Years): 9
Top Topics
Radiation Therapy
Pi K Akt
Acinetobacter Baumannii
Drug Resistant
Top Venues
Cancer research communications
Cancer informatics
Cancer chemotherapy and pharmacology
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Robert Chase Cockrell
,
David E Axelrod
Combination Chemotherapy of Multidrug-resistant Early-stage Colon Cancer: Determining Optimal Dose Schedules by High-performance Computer Simulation.
Cancer research communications
3 (1) (2023)
Robert Chase Cockrell
,
David E Axelrod
Combination Chemotherapy of Multidrug-resistant Early-stage Colon Cancer: Determining Optimal Dose Schedules by High-performance Computer Simulation.
Cancer research communications
3 (1) (2023)
Robert Chase Cockrell
,
David E Axelrod
Combination Chemotherapy of Multidrug-resistant Early-stage Colon Cancer: Determining Optimal Dose Schedules by High-performance Computer Simulation.
Cancer research communications
3 (1) (2023)
Robert Chase Cockrell
,
David E Axelrod
Combination Chemotherapy of Multidrug-resistant Early-stage Colon Cancer: Determining Optimal Dose Schedules by High-performance Computer Simulation.
Cancer research communications
3 (1) (2023)
Robert Chase Cockrell
,
David E Axelrod
Combination Chemotherapy of Multidrug-resistant Early-stage Colon Cancer: Determining Optimal Dose Schedules by High-performance Computer Simulation.
Cancer research communications
3 (1) (2023)
David E Axelrod
Chronotherapy of Early Colon Cancer: Advantage of Morning Dose Schedules.
Cancer informatics
21 (2022)
Derek Gordon
,
David E Axelrod
A reliable method to determine which candidate chemotherapeutic drugs effectively inhibit tumor growth in patient-derived xenografts (PDX) in single mouse trials.
Cancer chemotherapy and pharmacology
84 (6) (2019)
Robert Chase Cockrell
,
David E Axelrod
Optimization of Dose Schedules for Chemotherapy of Early Colon Cancer Determined by High-Performance Computer Simulations.
Cancer informatics
18 (2019)
David E Axelrod
,
Sudeepti Vedula
,
James Obaniyi
Effective chemotherapy of heterogeneous and drug-resistant early colon cancers by intermittent dose schedules: a computer simulation study.
Cancer chemotherapy and pharmacology
79 (5) (2017)